日本新薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/08/21 | 5,900 | 6,088 | 5,895 | 6,069 | +250 | +4.3% | 547,200 |
2023/08/18 | 5,714 | 5,832 | 5,651 | 5,819 | +105 | +1.8% | 411,100 |
2023/08/17 | 5,796 | 5,799 | 5,663 | 5,714 | -113 | -1.9% | 372,500 |
2023/08/16 | 5,820 | 5,875 | 5,765 | 5,827 | -58 | -1% | 477,300 |
2023/08/15 | 5,918 | 5,977 | 5,780 | 5,885 | -69 | -1.2% | 598,700 |
2023/08/14 | 6,037 | 6,299 | 5,934 | 5,954 | -15 | -0.3% | 1,013,200 |
2023/08/10 | 5,850 | 5,970 | 5,850 | 5,969 | +39 | +0.7% | 430,000 |
2023/08/09 | 5,824 | 5,949 | 5,785 | 5,930 | +155 | +2.7% | 578,900 |
2023/08/08 | 5,752 | 5,790 | 5,732 | 5,775 | +21 | +0.4% | 312,100 |
2023/08/07 | 5,653 | 5,754 | 5,641 | 5,754 | +78 | +1.4% | 306,000 |
2023/08/04 | 5,696 | 5,706 | 5,648 | 5,676 | -66 | -1.1% | 320,200 |
2023/08/03 | 5,774 | 5,776 | 5,679 | 5,742 | -44 | -0.8% | 365,600 |
2023/08/02 | 5,774 | 5,820 | 5,763 | 5,786 | -33 | -0.6% | 445,900 |
2023/08/01 | 5,761 | 5,819 | 5,734 | 5,819 | +65 | +1.1% | 397,300 |
2023/07/31 | 5,776 | 5,788 | 5,722 | 5,754 | +20 | +0.3% | 305,400 |
2023/07/28 | 5,650 | 5,752 | 5,603 | 5,734 | +54 | +1% | 412,800 |
2023/07/27 | 5,693 | 5,703 | 5,607 | 5,680 | -50 | -0.9% | 403,500 |
2023/07/26 | 5,696 | 5,745 | 5,686 | 5,730 | +50 | +0.9% | 377,800 |
2023/07/25 | 5,721 | 5,730 | 5,654 | 5,680 | -69 | -1.2% | 498,600 |
2023/07/24 | 5,676 | 5,749 | 5,639 | 5,749 | +144 | +2.6% | 490,500 |
2023/07/21 | 5,589 | 5,610 | 5,545 | 5,605 | +115 | +2.1% | 385,000 |
2023/07/20 | 5,536 | 5,546 | 5,484 | 5,490 | -36 | -0.7% | 338,300 |
2023/07/19 | 5,501 | 5,526 | 5,464 | 5,526 | +47 | +0.9% | 514,400 |
2023/07/18 | 5,460 | 5,550 | 5,427 | 5,479 | +36 | +0.7% | 394,700 |
2023/07/14 | 5,406 | 5,463 | 5,392 | 5,443 | +1 | ±0% | 338,500 |
2023/07/13 | 5,390 | 5,450 | 5,351 | 5,442 | +50 | +0.9% | 342,400 |
2023/07/12 | 5,389 | 5,413 | 5,340 | 5,392 | +6 | +0.1% | 366,500 |
2023/07/11 | 5,450 | 5,470 | 5,371 | 5,386 | -60 | -1.1% | 476,900 |
2023/07/10 | 5,428 | 5,470 | 5,366 | 5,446 | +22 | +0.4% | 523,100 |
2023/07/07 | 5,500 | 5,524 | 5,410 | 5,424 | -118 | -2.1% | 524,100 |
2023/07/06 | 5,706 | 5,714 | 5,500 | 5,542 | -169 | -3% | 545,500 |
2023/07/05 | 5,668 | 5,735 | 5,668 | 5,711 | +28 | +0.5% | 321,700 |
2023/07/04 | 5,724 | 5,751 | 5,656 | 5,683 | -121 | -2.1% | 587,300 |
2023/07/03 | 5,910 | 5,945 | 5,804 | 5,804 | -70 | -1.2% | 473,700 |
2023/06/30 | 5,980 | 5,980 | 5,872 | 5,874 | -178 | -2.9% | 509,000 |
2023/06/29 | 6,079 | 6,119 | 5,994 | 6,052 | -2 | ±0% | 434,200 |
2023/06/28 | 6,024 | 6,069 | 5,980 | 6,054 | +25 | +0.4% | 433,100 |
2023/06/27 | 6,149 | 6,149 | 5,977 | 6,029 | -179 | -2.9% | 541,700 |
2023/06/26 | 6,200 | 6,218 | 6,070 | 6,208 | ±0 | ±0% | 375,000 |
2023/06/23 | 6,369 | 6,380 | 6,200 | 6,208 | -109 | -1.7% | 376,800 |
2023/06/22 | 6,375 | 6,427 | 6,310 | 6,317 | -107 | -1.7% | 307,200 |
2023/06/21 | 6,479 | 6,548 | 6,420 | 6,424 | -3 | ±0% | 358,100 |
2023/06/20 | 6,452 | 6,470 | 6,394 | 6,427 | -57 | -0.9% | 211,500 |
2023/06/19 | 6,539 | 6,592 | 6,453 | 6,484 | +17 | +0.3% | 275,700 |
2023/06/16 | 6,373 | 6,514 | 6,361 | 6,467 | +89 | +1.4% | 504,000 |
2023/06/15 | 6,455 | 6,505 | 6,378 | 6,378 | -125 | -1.9% | 287,200 |
2023/06/14 | 6,547 | 6,586 | 6,450 | 6,503 | -37 | -0.6% | 344,400 |
2023/06/13 | 6,597 | 6,683 | 6,516 | 6,540 | -21 | -0.3% | 436,200 |
2023/06/12 | 6,516 | 6,672 | 6,513 | 6,561 | +77 | +1.2% | 256,000 |
2023/06/09 | 6,516 | 6,546 | 6,453 | 6,484 | +68 | +1.1% | 257,600 |
401~
450
件表示中 / 3677件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
日本新薬 | 352,900円 | +7.9% | +8.9% | 3.51% | 7.55倍 | 1.01倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
ツムラ | 413,600円 | +20.9% | +87.3% | 3.29% | 9.24倍 | 1.06倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
サワイGHD | 191,500円 | +4.0% | +25.4% | 2.77% | 8.37倍 | 1.10倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
ペプチド | 188,300円 | +5.0% | +1.5% | 0.00% | 16.16倍 | 4.30倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
住友ファーマ | 54,600円 | +21.1% | - | 0.00% | 13.56倍 | 1.90倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
市場注目の銘柄
チャート関連のコラム